These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 24957792)

  • 1. Hyperhaemolysis in a patient with HbH disease.
    Danaee A; Howard J; Robertson B; Robinson S
    Transfus Med; 2014 Aug; 24(4):244-5. PubMed ID: 24957792
    [No Abstract]   [Full Text] [Related]  

  • 2. Hemolytic adverse events with immune globulin products: product factors and patient risks.
    Scott DE; Epstein JS
    Transfusion; 2015 Jul; 55 Suppl 2():S2-5. PubMed ID: 26174893
    [No Abstract]   [Full Text] [Related]  

  • 3. Editors' Notes.
    Klein HG; Schreiber GB
    Transfusion; 2015 Jul; 55 Suppl 2():S1. PubMed ID: 26174886
    [No Abstract]   [Full Text] [Related]  

  • 4. Use of intravenous immunoglobulin and intravenous methylprednisolone in hyperhaemolysis syndrome in sickle cell disease.
    Win N; Yeghen T; Needs M; Chen FE; Okpala I
    Hematology; 2004; 9(5-6):433-6. PubMed ID: 15763986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous immunoglobulin: adverse reactions and management.
    Bonilla FA
    J Allergy Clin Immunol; 2008 Dec; 122(6):1238-9. PubMed ID: 18842292
    [No Abstract]   [Full Text] [Related]  

  • 6. Hemolysis upon intravenous immunoglobulin transfusion.
    Padmore RF
    Transfus Apher Sci; 2012 Feb; 46(1):93-6. PubMed ID: 22169381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous immunoglobulin induced meningoencephalitis.
    Nooraine J; Iyer RB; Raghavendra S
    Neurol India; 2014; 62(1):98-9. PubMed ID: 24608480
    [No Abstract]   [Full Text] [Related]  

  • 8. Intravenous immune globulin-related hemolysis: comparing two different methods for case assessment.
    Taylor E; Vu D; Legare C; Keene D
    Transfusion; 2015 Jul; 55 Suppl 2():S23-7. PubMed ID: 26174894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complementary use of passive surveillance and Mini-Sentinel to better characterize hemolysis after immune globulin.
    Winiecki S; Baer B; Chege W; Jankosky C; Mintz P; Baker M; Woodworth T; Nguyen M
    Transfusion; 2015 Jul; 55 Suppl 2():S28-35. PubMed ID: 26174895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperhaemolysis syndrome in haemoglobin E / beta thalassaemia responding to cyclophosphamide therapy.
    Senanayake MP; Kuruppu KK; Sumanasena SP; Lamabadusuriya SP
    Ceylon Med J; 2008 Dec; 53(4):134-5. PubMed ID: 19189792
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinically significant pseudohyponatremia.
    Bern M
    Am J Hematol; 2006 Jul; 81(7):558-9. PubMed ID: 16755556
    [No Abstract]   [Full Text] [Related]  

  • 12. Hyperhaemolysis in sickle cell disease--an unusual and potentially life-threatening complication.
    Stokes IC; Downie PA; Wood EM; Bowden DK; Monagle PT; Barnes CD
    Med J Aust; 2010 Mar; 192(5):281-2. PubMed ID: 20201763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Occurrence of anti-HPA-5b alloantibodies during intravenous immunoglobulin treatment in an HPA-15b alloimmunised woman: a case report.
    Moncharmont P; Makowski C; Equy V; Andrini P; Rigal D
    Transfus Med; 2013 Jun; 23(3):202-3. PubMed ID: 23402651
    [No Abstract]   [Full Text] [Related]  

  • 14. Severe dyshidrotic eczema after intravenous immunoglobulin therapy for Kawasaki syndrome.
    Shiraishi T; Yamamoto T
    Pediatr Dermatol; 2013; 30(3):e30-1. PubMed ID: 22304420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous immunoglobulin-induced haemolysis: a case report and review of the literature.
    Desborough MJ; Miller J; Thorpe SJ; Murphy MF; Misbah SA
    Transfus Med; 2014 Aug; 24(4):219-26. PubMed ID: 24164446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute hemolysis secondary to high-dose intravenous immunoglobulin in a patient with Stevens-Johnson syndrome.
    Shakouri AA; Bahna SL
    Ann Allergy Asthma Immunol; 2012 Jun; 108(6):463-4. PubMed ID: 22626604
    [No Abstract]   [Full Text] [Related]  

  • 17. Severe exacerbation of psoriasis after intravenous immunoglobulin in patient with multiple sclerosis that started during biologic therapy.
    Ettler J; Arenberger P; Arenbergerova M; Gkalpakiotis S
    J Eur Acad Dermatol Venereol; 2016 Feb; 30(2):355-6. PubMed ID: 25327640
    [No Abstract]   [Full Text] [Related]  

  • 18. Successful management of the potentially fatal hyperhaemolysis syndrome of sickle cell anaemia with a regimen including bortezomib and Hemopure.
    Epstein SS; Hadley TJ
    J Clin Pharm Ther; 2019 Oct; 44(5):815-818. PubMed ID: 31237703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Necrotizing enterocolitis in a newborn following intravenous immunoglobulin treatment for haemolytic disease.
    Kara S; Ulu-ozkan H; Yilmaz Y; Arikan FI; Dilmen U; Bilge YD
    J Coll Physicians Surg Pak; 2013 Aug; 23(8):598-600. PubMed ID: 23930883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemoglobinuria and acute kidney injury requiring hemodialysis following intravenous immunoglobulin infusion.
    Welles CC; Tambra S; Lafayette RA
    Am J Kidney Dis; 2010 Jan; 55(1):148-51. PubMed ID: 19628320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.